Skip to main content
Erschienen in: Japanese Journal of Radiology 1/2018

03.11.2017 | Original Article

Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients

verfasst von: Cem Onal, Yemliha Dölek, Berna Akkuş Yıldırım

Erschienen in: Japanese Journal of Radiology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare dosimetric data for the planning target volume (PTV) and organs at risk (OARs) between 3-dimensional conformal radiotherapy (3DCRT), volumetric modulated arc therapy (VMAT), and helical tomotherapy [1].

Materials and methods

The dosimetric data for 15 gastric cancer patients treated with 3DCRT, VMAT, or HT techniques were used. Cumulative dosimetric parameters, homogeneity index (HI), and conformal index (CI) were compared for the PTV and OARs.

Results

The average maximum doses of PTV were significantly higher in VMAT plans than in 3DCRT (p = 0.04) and HT (p = 0.02) plans, whereas minimum dose values were significantly lower in 3DCRT plans compared with VMAT (p < 0.001) and HT (p = 0.02) plans. Liver mean dose (D mean) and D mean values for both kidneys were significantly lower in HT plans than in 3DCRT and VMAT plans. The doses in high dose regions (V30–V45) using 3DCRT plans were significantly higher compared to both VMAT and HT plans. The bowel V5–V30 and V45 was significantly less in HT plans compared to VMAT plans. There were no significant differences in dose sparing of the spinal cord.

Conclusions

The HT plans reduced the maximum dose applied to the target and improved the conformality and homogeneity of radiation, while providing sufficient PTV coverage.
Literatur
1.
Zurück zum Zitat Olatunji BO, Ebesutani C, Sawchuk CN, et al. Development and initial validation of the medical fear survey-short version. Assessment. 2012;19(3):318–36.PubMedCrossRef Olatunji BO, Ebesutani C, Sawchuk CN, et al. Development and initial validation of the medical fear survey-short version. Assessment. 2012;19(3):318–36.PubMedCrossRef
2.
Zurück zum Zitat Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.PubMedCrossRef Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.PubMedCrossRef
3.
Zurück zum Zitat Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982;8(1):1–11.PubMedCrossRef Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982;8(1):1–11.PubMedCrossRef
4.
Zurück zum Zitat Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–30.PubMedCrossRef Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–30.PubMedCrossRef
5.
Zurück zum Zitat Valentini V, Cellini F, Minsky BD, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol. 2009;92(2):176–83.PubMedCrossRef Valentini V, Cellini F, Minsky BD, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol. 2009;92(2):176–83.PubMedCrossRef
6.
Zurück zum Zitat Kim S, Lim DH, Lee J, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys. 2005;63(5):1279–85.PubMedCrossRef Kim S, Lim DH, Lee J, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys. 2005;63(5):1279–85.PubMedCrossRef
7.
Zurück zum Zitat Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003;56(1):145–57.PubMedCrossRef Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003;56(1):145–57.PubMedCrossRef
8.
Zurück zum Zitat Hummel S, Simpson EL, Hemingway P, et al. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technol Assess. 2010;14(47):1–108.PubMedCrossRef Hummel S, Simpson EL, Hemingway P, et al. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation. Health Technol Assess. 2010;14(47):1–108.PubMedCrossRef
9.
Zurück zum Zitat Alani S, Soyfer V, Strauss N, et al. Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):562–6.PubMedCrossRef Alani S, Soyfer V, Strauss N, et al. Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):562–6.PubMedCrossRef
10.
Zurück zum Zitat Milano MT, Garofalo MC, Chmura SJ, et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol. 2006;79(942):497–503.PubMedCrossRef Milano MT, Garofalo MC, Chmura SJ, et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol. 2006;79(942):497–503.PubMedCrossRef
11.
Zurück zum Zitat Li Z, Zeng J, Wang Z, et al. Dosimetric comparison of intensity modulated and volumetric arc radiation therapy for gastric cancer. Oncol Lett. 2014;8(4):1427–34.PubMedPubMedCentral Li Z, Zeng J, Wang Z, et al. Dosimetric comparison of intensity modulated and volumetric arc radiation therapy for gastric cancer. Oncol Lett. 2014;8(4):1427–34.PubMedPubMedCentral
12.
Zurück zum Zitat Zhang T, Liang ZW, Han J, et al. Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer. Radiat Oncol. 2015;10:114.PubMedPubMedCentralCrossRef Zhang T, Liang ZW, Han J, et al. Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer. Radiat Oncol. 2015;10:114.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Wang X, Li G, Zhang Y, et al. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT). Med Dosim. 2013;38(4):395–400.PubMedCrossRef Wang X, Li G, Zhang Y, et al. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT). Med Dosim. 2013;38(4):395–400.PubMedCrossRef
14.
Zurück zum Zitat Dahele M, Skinner M, Schultz B, et al. Adjuvant radiotherapy for gastric cancer: a dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans. Med Dosim. 2010;35(2):115–21.PubMedCrossRef Dahele M, Skinner M, Schultz B, et al. Adjuvant radiotherapy for gastric cancer: a dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans. Med Dosim. 2010;35(2):115–21.PubMedCrossRef
15.
Zurück zum Zitat Pardo-Montero J, Fenwick JD. An approach to multiobjective optimization of rotational therapy. Med Phys. 2009;36(7):3292–303.PubMedCrossRef Pardo-Montero J, Fenwick JD. An approach to multiobjective optimization of rotational therapy. Med Phys. 2009;36(7):3292–303.PubMedCrossRef
16.
Zurück zum Zitat Taylor R, Opfermann K, Jones BD, et al. Comparison of radiation treatment delivery for pancreatic cancer: linac intensity-modulated radiotherapy versus helical tomotherapy. J Med Imaging Radiat Oncol. 2012;56(3):332–7.PubMedCrossRef Taylor R, Opfermann K, Jones BD, et al. Comparison of radiation treatment delivery for pancreatic cancer: linac intensity-modulated radiotherapy versus helical tomotherapy. J Med Imaging Radiat Oncol. 2012;56(3):332–7.PubMedCrossRef
17.
Zurück zum Zitat Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310–7.PubMedCrossRef Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310–7.PubMedCrossRef
18.
Zurück zum Zitat Onal C, Arslan G, Parlak C, et al. Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer. Jpn J Radiol. 2014;32(4):224–32.PubMedCrossRef Onal C, Arslan G, Parlak C, et al. Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer. Jpn J Radiol. 2014;32(4):224–32.PubMedCrossRef
19.
Zurück zum Zitat Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol. 2004;71(2):201–6.PubMedCrossRef Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol. 2004;71(2):201–6.PubMedCrossRef
20.
Zurück zum Zitat Tepper JE, Gunderson LL. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer. Semin Radiat Oncol. 2002;12(2):187–95.PubMedCrossRef Tepper JE, Gunderson LL. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer. Semin Radiat Oncol. 2002;12(2):187–95.PubMedCrossRef
21.
Zurück zum Zitat Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52(2):283–93.PubMedCrossRef Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52(2):283–93.PubMedCrossRef
22.
Zurück zum Zitat Leong T, Willis D, Joon DL, et al. 3D conformal radiotherapy for gastric cancer—results of a comparative planning study. Radiother Oncol. 2005;74(3):301–6.PubMedCrossRef Leong T, Willis D, Joon DL, et al. 3D conformal radiotherapy for gastric cancer—results of a comparative planning study. Radiother Oncol. 2005;74(3):301–6.PubMedCrossRef
24.
Zurück zum Zitat Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53(4):810–21.PubMedCrossRef Dawson LA, Normolle D, Balter JM, et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys. 2002;53(4):810–21.PubMedCrossRef
25.
Zurück zum Zitat Liang SX, Zhu XD, Xu ZY, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys. 2006;65(2):426–34.PubMedCrossRef Liang SX, Zhu XD, Xu ZY, et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys. 2006;65(2):426–34.PubMedCrossRef
26.
Zurück zum Zitat Kuo YC, Chiu YM, Shih WP, et al. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol. 2011;6:76.PubMedPubMedCentralCrossRef Kuo YC, Chiu YM, Shih WP, et al. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol. 2011;6:76.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Ringash J, Perkins G, Brierley J, et al. IMRT for adjuvant radiation in gastric cancer: a preferred plan? Int J Radiat Oncol Biol Phys. 2005;63(3):732–8.PubMedCrossRef Ringash J, Perkins G, Brierley J, et al. IMRT for adjuvant radiation in gastric cancer: a preferred plan? Int J Radiat Oncol Biol Phys. 2005;63(3):732–8.PubMedCrossRef
28.
Zurück zum Zitat Minn AY, Hsu A, La T, et al. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer. Cancer. 2010;116(16):3943–52.PubMedCrossRef Minn AY, Hsu A, La T, et al. Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer. Cancer. 2010;116(16):3943–52.PubMedCrossRef
29.
Zurück zum Zitat Binny D, Lancaster CM, Harris S, et al. Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans. J Appl Clin Med Phys. 2015;16(5):5282.CrossRef Binny D, Lancaster CM, Harris S, et al. Effects of changing modulation and pitch parameters on tomotherapy delivery quality assurance plans. J Appl Clin Med Phys. 2015;16(5):5282.CrossRef
30.
Zurück zum Zitat Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31(5):1249–56.PubMedCrossRef Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31(5):1249–56.PubMedCrossRef
31.
Zurück zum Zitat Jansen EP, Saunders MP, Boot H, et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2007;67(3):781–5.PubMedCrossRef Jansen EP, Saunders MP, Boot H, et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2007;67(3):781–5.PubMedCrossRef
32.
Zurück zum Zitat Boda-Heggemann J, Hofheinz RD, Weiss C, et al. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer. Int J Radiat Oncol Biol Phys. 2009;75(4):1187–95.PubMedCrossRef Boda-Heggemann J, Hofheinz RD, Weiss C, et al. Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer. Int J Radiat Oncol Biol Phys. 2009;75(4):1187–95.PubMedCrossRef
33.
Zurück zum Zitat Rong Y, Chen Y, Shang L, et al. Helical tomotherapy with dynamic running-start-stop delivery compared to conventional tomotherapy delivery. Med Phys. 2014;41(5):051709.PubMedCrossRef Rong Y, Chen Y, Shang L, et al. Helical tomotherapy with dynamic running-start-stop delivery compared to conventional tomotherapy delivery. Med Phys. 2014;41(5):051709.PubMedCrossRef
34.
Zurück zum Zitat Katayama S, Haefner MF, Mohr A, et al. Accelerated tomotherapy delivery with TomoEdge technique. J Appl Clin Med Phys. 2015;16(2):4964.PubMedCrossRef Katayama S, Haefner MF, Mohr A, et al. Accelerated tomotherapy delivery with TomoEdge technique. J Appl Clin Med Phys. 2015;16(2):4964.PubMedCrossRef
35.
Zurück zum Zitat Fiorino C, Alongi F, Perna L, et al. Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 2009;75(1):29–35.PubMedCrossRef Fiorino C, Alongi F, Perna L, et al. Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 2009;75(1):29–35.PubMedCrossRef
36.
Zurück zum Zitat Wang X, Tian Y, Tang Y, et al. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy. Oncotarget. 2017;8(24):39727–35.PubMedPubMedCentral Wang X, Tian Y, Tang Y, et al. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy. Oncotarget. 2017;8(24):39727–35.PubMedPubMedCentral
37.
Zurück zum Zitat Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93(2):226–33.PubMedCrossRef Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol. 2009;93(2):226–33.PubMedCrossRef
Metadaten
Titel
Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients
verfasst von
Cem Onal
Yemliha Dölek
Berna Akkuş Yıldırım
Publikationsdatum
03.11.2017
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 1/2018
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-017-0696-x

Weitere Artikel der Ausgabe 1/2018

Japanese Journal of Radiology 1/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.